Abstract

Radiomic feature analysis has been shown to be effective at analyzing diagnostic images to model cancer outcomes. It has not yet been established how to best combine radiomic features in cancer patients with multifocal tumors. As the number of patients with multifocal metastatic cancer continues to rise, there is a need for improving personalized patient-level prognosis to better inform treatment. We compared six mathematical methods of combining radiomic features of 3,596 tumors in 831 patients with multiple brain metastases and evaluated the performance of these aggregation methods using three survival models: a standard Cox proportional hazards model, a Cox proportional hazards model with LASSO regression, and a random survival forest. Across all three survival models, the weighted average of the largest three metastases had the highest concordance index (95% confidence interval) of 0.627 (0.595–0.661) for the Cox proportional hazards model, 0.628 (0.591–0.666) for the Cox proportional hazards model with LASSO regression, and 0.652 (0.565–0.727) for the random survival forest model. This finding was consistent when evaluating patients with different numbers of brain metastases and different tumor volumes. Radiomic features can be effectively combined to estimate patient-level outcomes in patients with multifocal brain metastases. Future studies are needed to confirm that the volume-weighted average of the largest three tumors is an effective method for combining radiomic features across other imaging modalities and tumor types.

Details

Title
Comparison of radiomic feature aggregation methods for patients with multiple tumors
Author
Chang, Enoch 1 ; Joel, Marina Z 1 ; Chang, Hannah Y 2 ; Du, Justin 3 ; Khanna Omaditya 4 ; Omuro Antonio 5 ; Chiang, Veronica 6 ; Aneja Sanjay 7 

 Yale School of Medicine, Department of Therapeutic Radiology, New Haven, USA 
 Massachusetts Institute of Technology, Cambridge, USA 
 Yale College, New Haven, USA 
 Thomas Jefferson University, Department of Neurosurgery, Philadelphia, USA 
 Yale Brain Tumor Center, New Haven, USA 
 Yale School of Medicine, Department of Neurosurgery, New Haven, USA 
 Yale School of Medicine, Department of Therapeutic Radiology, New Haven, USA; Yale Brain Tumor Center, New Haven, USA; Yale School of Medicine, Center for Outcomes Research and Evaluation, New Haven, USA 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2522964939
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.